Psoriatic Arthritis Treatment Market Size, Share, Growth, and Industry Analysis, By Type (Kits, Reagents, Instruments), By Application (Hospitals, Clinics, Ambulatory Surgery Centers, Diagnostic Laboratories), and Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

PSORIATIC ARTHRITIS TREATMENT MARKET OVERVIEW

The global psoriatic arthritis treatment market size was USD 9.86 billion in 2026 and is projected to touch USD 16.23 billion by 2035, exhibiting a CAGR of 5.7% during the forecast period.

The market for the treatment of PsA has been growing rapidly due to the increased prevalence of psoriatic disease and greater awareness of early diagnosis. Rapid advances in immunology have resulted in a surge of research focused on inflammatory pathways that drive both joint and skin symptoms. With chronic disease management now at the forefront, patients and physicians are moving toward therapies administered long-term, which consistently control symptoms and improve mobility while preventing joint damage.

Over the past few years, the market has witnessed stellar growth driven by biologics, small-molecule drugs, and biosimilars. Companies are investing heavily in next-generation therapies that offer greater specificity, quicker onset of action, and fewer side effects. Upcoming treatments targeting IL-17, IL-23, and JAK pathways are reshaping competitive dynamics, while improved access to healthcare and insurance coverage is further expanding the patient pool. Overall, treatment in psoriatic arthritis is being directed toward more personalized, effective, and sustainable options.

COVID-19 IMPACT

Psoriatic Arthritis Treatment Industry Had a positive Effect Due to increase in research and development during COVID-19 Pandemic.

Covid-19 had a notable impact on the Psoriatic Arthritis Treatment market share. The world is still witnessing unprecedented and staggering global COVID-19 pandemic, where the market is enjoying more demand than expected in all regions than it was before the pandemic. The unexpected growth of the market as indicated by the growth of CAGR can be explained by the fact that the market has been growing and the demand is back to pre-pandemic levels.

The market of the Psoriatic Arthritis Treatment was strongly impacted by the COVID-19 pandemic. Because of lockdowns and social distancing, a large number of patients could not visit medical facilities, which resulted in late diagnosis and treatment. This has led to the amplification of the disease activity thereby the necessity of using biologics and other systemic medicines. Therefore, the demand of these treatments rose leading to the expansion of the market. Furthermore, the pandemic boosted the use of digital health technology, which includes telemedicine and remote monitoring, to enhance patient interaction and compliance with treatment.

The pandemic also contributed to the growth of research and development in the new treatment of Psoriatic Arthritis. Pharmaceutical firms hastened the production of the treatment of COVID-19, using the available infrastructure and experience in the field of the creation of vaccines, which can be transferred to the treatment of Psoriatic Arthritis. Moreover, the pandemic emphasized the necessity of individual medicine and precision treatment methods, and therefore, there was an interest in novel biomarkers and therapeutic targets of Psoriatic Arthritis. Such high emphasis on research and development will likely become the source of innovation and growth in the Psoriatic Arthritis Treatment market in the long term.

LATEST TRENDS

Rise in adoption of Biosimilar Therapies to Drive Market Growth

Increase in Adoption of Biosimilar Therapies is spurring the growth in the Psoriatic Arthritis Treatment market because the alternative biologics are cost effective and more accessible to patients. Biosimilars are very effective in the treatment of moderate to severe psoriatic arthritis. The major market players are increasing their product lines to accommodate biosimilars. The growing need of biosimilars is explained by the possibility to achieve its long-term effect. Approval of biosimilars has been scaled down to a smooth flow in the last few years. This is likely to increase the number of biosimilar treatments.

•   
•   
  

  Download Free Sample to learn more about this report

    

PSORIATIC ARTHRITIS TREATMENT MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Kits, Reagents, Instruments.

• Kits: Psoriatic Arthritis Treatment Kits market deals with the sale of readymade diagnostic and treatment packages to psoriatic arthritis patients. Such kits may contain biologics, oral drugs, or topical ointments or creams. They offer treatment to different stages of the disease making them able to treat both mild, moderate and severe cases.

• Reagents: The market of Psoriatic Arthritis Treatment Reagents is devoted to the manufacturing and sale of chemical substances that are applied in laboratory tests and diagnostics. ELISA kit, PCR reagents and immunohistochemistry reagents are also used to diagnose and monitor psoriatic arthritis. They make the treatment of healthcare professionals more precise and timelier.

• Instruments: Psoriatic Arthritis Treatment Instruments market entails creation and sale of medical equipment that is employed in the diagnosis and treatment of psoriatic arthritis. These machines are ultrasound machines, MRI machines and X-ray machines which help in imaging and diagnosis. Moreover, therapeutic equipment like injections and infusion pump also falls under this market.

By Application

Based on application, the global market can be categorized into Hospitals, Clinics, Ambulatory Surgery Centers, Diagnostic Laboratories.

• Hospitals: The Hospitals application of the Psoriatic Arthritis Treatment market deals with in-patient treatment and management of the severe cases which will need intensive care and medication. The services offered in hospitals are diagnosis, treatment and rehabilitation. They also provide multidisciplinary services of rheumatologists, dermatologists and others.

• Clinics: Psoriatic Arthritis Treatment market is aimed at treating and managing mild to moderate cases of psoriatic arthritis in outpatients. Clinics provide standard check-ups, medication and education to patients. They usually have a group of medical personnel such as nurses, physical therapists and psychologists.

• Ambulatory Surgery Centers: The Psoriatic Arthritis Treatment market of the application of the ASCs entails surgical operations like joint injections and biologic infusions. Such facilities will offer patients in need of surgical procedures a convenient and affordable way of treatment. They have up to date facilities and are manned by well qualified medical staff.

• Diagnostic Laboratories: Psoriatic Arthritis Treatment market Diagnostic Laboratories application is instrumental in the diagnosis of the disease and monitoring. Laboratories perform multiple tests such as blood tests, imaging to detect the disease and follow-up of the progression of the disease. They provide the crucial information to the healthcare providers to inform the decision-making on treatment.

MARKET DYNAMICS

Driving Factors

Rising Prevalence of Psoriatic Arthritis to Boost the Market

A factor in the Psoriatic Arthritis Treatment market growth is the Rising Prevalence of Psoriatic Arthritis. One of the market forces driving the treatment psoriatic arthritis, in fact, is the rising prevalence of the illness in the world. Psoriatic arthritis is a disease associated with psoriasis and has been on the rise throughout the world due to a number of demographic and lifestyle factors. The growing age particularly in the developed world has greatly exaggerated the possibility of adults to suffer chronic inflammatory and autoimmune diseases. This together with the increased awareness of the disease among patients and medical professionals results in the identification of the signs of a psoriatic disease at an earlier stage and also makes the latter more aware of the condition in question as a serious and progressive one. With the increased number of patients presenting themselves to the medical centers with the symptoms of psoriasis related to joint pain, the need to find an effective treatment modality grows tremendously. The growing number of patients and the chronicity of the PsA would guarantee the patients continuous demand of therapeutic interventions which would guarantee the treatment market to grow sustainably in the coming years.

Advancements in Biologic Therapies to Expand the Market

The second force that has a significant influence on the psoriatic arthritis treatment market is the rapid adoption and development of biologic therapy. Biologics have transformed the treatment of PsA with the provision of specific mechanisms of action that directly focus on the individual inflammatory pathways that produce both joint and skin symptoms. These treatments, including TNF blockers, IL-17 and IL-23 blockers have been exceptional in alleviating symptoms, averting joint destruction, increasing the people with chronic pangs and disability mobility, and general quality of life. Their high effectiveness, together with constant clinical research, have provided new opportunities of individual treatment programs. The market competitiveness is enhanced by the presence of a large pipeline of next-generation biologics and biosimilars which are expected to force pharmaceutical companies to invest in novel formulations and delivery systems. Therefore, biologic therapies do not only occupy the new PsA treatment environment but also provide substantial growth potential to industry actors to target unmet medical demands and come up with more effective long-term solution.

Restraining Factor

High Costs of Treatment to Potentially Impede Market Growth

The cost of treatment is a limiting force in the market of the psoriatic arthritis treatment. Most patients cannot afford the high cost of drugs and treatments that are needed to treat the condition. Limiting access to care by those who most need it can be caused by the high cost of treatment. This may result in late diagnosis and treatment worsening of the condition and diminishing quality of life. Treatment of psoriatic arthritis may also affect the capacity of the patients to work and generate income due to the financial strain. Consequently, the general effect of the disease may be even worse.

Emerging Biotechnology Opportunities to Create Opportunity for the Product in the Market

Opportunity

One of the technologies that can be exploited in the Psoriatic Arthritis Treatment market to make a significant amount of money is the development of gene editing therapy capable of targeting some genetic mutations causing the disease. Using the CRISPR technology, scientists are in optimism that they will come up with specific therapy that is tailor-made and one that can detect and target undesired genes, and possibly avert the progression of Psoriatic Arthritis. This kind of strategy can be used to offer disease management and symptom reduction in the long run increasing the quality of life of millions of patients across the world.

Secondly, gene editing therapies can be designed as able to address multiple genetic variants simultaneously hence, they are useful forms of treatment as well compared to traditional therapies. In the future, Psoriatic Arthritis will have a revolutionary therapy that involves gene editing therapy, which will be achieved through advanced research and development. In the coming years, Psoriatic Arthritis Treatment market is bound to be altered with this innovation.

Personalized 3D Printed Joint Implants for Psoriatic Arthritis Patients Could Be a Potential Challenge for Consumers

Challenge

The escalated rate of psoriatic arthritis has contributed to a higher need of more effective and individualized treatment methods. A major problem facing this market is the requirement to have more speculative and versatile joint implants that can be adjusted to fit the needs of specific patients.

This has brought about a challenge of futurism to create 3D printed joint implants which can be tailored to be specific to the anatomy and medical history of patients. This type of implants would be more accurate and this would reduce the chances of complications to occur and the overall outcomes of a patient there would be better. The development of AI and bioprinting makes this issue more possible.

•   
•   
  Download Free Sample to learn more about this report

    

PSORIATIC ARTHRITIS TREATMENT MARKET REGIONAL INSIGHTS

• North America

North America is the fastest-growing region in this market. The United States Psoriatic Arthritis Treatment market has been growing exponentially owing to multiple reasons. The appearance of such key players like AbbVie, Johnson and Johnson, and Pfizer drives the psoriatic arthritis treatment market in North America. The growth of the market is driven by high demand of biologics and oral small molecules. New forms of treatment and therapy are also extensively adopted in the region. The growth of the market is also due to the rising prevalence of psoriatic arthritis and the increasing amount of healthcare spending. The reimbursement situation is also favorable which also enhances the growth of the market.

• Europe

The European psoriatic arthritis treatment market is very similar with a high rate of uptake of biologics and oral small molecules. The market is dominated by the giants like Novartis, Merck & Co and UCB Pharmaceutical. Government regulation and policies affect the pharmaceutical market of the region. The rising interest in personalized medicine and the growing number of biologics contributes to the market expansion. The psoriatic arthritis treatment market in Europe is also due to an increased awareness of the disease.

• Asia

Similar to the rising prevalence rate of psoriasis and psoriatic arthritis, the psoriatic arthritis treatment market in the Asia Pacific region is made up of the increasing prevalence of psoriasis and psoriatic arthritis. The business environment is marked by an increase in the demand of biologics and oral small molecules. The presence of such major players as Pfizer, Novartis, and Eli Lilly is growing in the region. The markets of China, Japan, and India are emerging as important markets owing to an increasing middle-income group and the development of a healthcare system. This market will grow tremendously in the Asia Pacific region due to the growing use of new treatments and therapies.   

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key industry players are shaping the psoriatic arthritis treatment marketplace through strategic innovation and market expansion. These companies are introducing advanced techniques and processes to improve the quality and performance of their offerings. They are also expanding their product lines to include specialized variations, catering to diverse customer preferences. Additionally, they are leveraging digital platforms to increase market reach and enhance distribution efficiency. By investing in research and development, optimizing supply chain operations, and exploring new regional markets, these players are driving growth and setting trends within the psoriatic arthritis treatment.

List Of Top Psoriatic Arthritis Treatment Companies

• Eli Lilly [U.S.]
• Roche [Switzerland]
• Merck [Germany]
• Novartis [Switzerland]
• Abbvie [Ireland]

KEY INDUSTRY DEVELOPMENT

July 2023: Skyrizi is an IL-23 (interleukin 23) blocker, which suppresses inflammation, destruction of joints, and skin manifestations of psoriatic arthritis. Its dosage schedule permits maintenance injections every-12-weekly following loading doses, enhancing patient compliance and adherence. A clinical trial showed a significant improvement in the functioning of the joints, skin clearance as well as physical functionality, providing a focused biologic therapy to moderate to severe patients of PsA.

REPORT COVERAGE

SWOT analysis is presented in this work at a high level, and helpful recommendations regarding further evolvement of the market are considered. This paper takes an opportunity to review and discuss the market segments and possible applications that have the potential to influence the market growth in the future years. The psoriatic arthritis treatment with better portability is expected to gain high growth rates due to better consumer adoption trends, increasing application areas, and more innovative product developments. Yet, there might be some problems like, for instance, the shortage of raw materials or higher prices for them. However, the growing popularity of specialized offerings and tendencies towards enhancing quality foster the growth of the market. All of them are progressing through technology and innovative strategies in developments as well as in supply chain and market. Due to changes in the market environment and growing demand for variety, the psoriatic arthritis treatment has a promising development since it constantly develops and expands its application.